Furthermore, additional CLRs that may have other roles in COVID-19 (BDCA-2; CLEC2; Dectin-1 and -2; DCIR; DNGR1; LOX-1; LSECtin) [196,197,198,199,200,201,202,203], such as contributing to immunopathological manifestations and severe symptoms experienced by COVID-19 patients, will also be explored. This evidence concerns the gene LARS1 and COVID-19.